Literature DB >> 15545626

The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila.

Jan H Reiling1, Ernst Hafen.   

Abstract

Diverse extrinsic and intrinsic cues must be integrated within a developing organism to ensure appropriate growth at the cellular and organismal level. In Drosophila, the insulin receptor/TOR/S6K signaling network plays a fundamental role in the control of metabolism and cell growth. Here we show that scylla and charybdis, two homologous genes identified as growth suppressors in an EP (enhancer/promoter) overexpression screen, act as negative regulators of growth. The simultaneous loss of both genes generates flies that are more susceptible to reduced oxygen concentrations (hypoxia) and that show mild overgrowth phenotypes. Conversely, scylla or charybdis overactivation reduces growth. Growth inhibition is associated with a reduction in S6K but not PKB/Akt activity. Together, genetic and biochemical analysis places Scylla/Charybdis downstream of PKB and upstream of TSC. Furthermore, we show that scylla and charybdis are induced under hypoxic conditions and that scylla is a target of Drosophila HIF-1 (hypoxia-inducible factor-1) like its mammalian counterpart RTP801/REDD1, thus establishing a potential cross-talk between growth and oxygen sensing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545626      PMCID: PMC534649          DOI: 10.1101/gad.322704

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  69 in total

1.  Ligand-independent activation of the sevenless receptor tyrosine kinase changes the fate of cells in the developing Drosophila eye.

Authors:  K Basler; B Christen; E Hafen
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

2.  Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4.

Authors:  R Böhni; J Riesgo-Escovar; S Oldham; W Brogiolo; H Stocker; B F Andruss; K Beckingham; E Hafen
Journal:  Cell       Date:  1999-06-25       Impact factor: 41.582

3.  Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling.

Authors:  Thomas Radimerski; Jacques Montagne; Maja Hemmings-Mieszczak; George Thomas
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

4.  Drosophila Thor participates in host immune defense and connects a translational regulator with innate immunity.

Authors:  A Bernal; D A Kimbrell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.

Authors:  Yijiang Shi; Joseph Gera; Liping Hu; Jung-hsin Hsu; Robert Bookstein; Weiqun Li; Alan Lichtenstein
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

Review 6.  Tuberous sclerosis complex: from Drosophila to human disease.

Authors:  Duojia Pan; Jixin Dong; Yong Zhang; Xinsheng Gao
Journal:  Trends Cell Biol       Date:  2004-02       Impact factor: 20.808

7.  A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets.

Authors:  Andrew M Arsham; Jessica J Howell; M Celeste Simon
Journal:  J Biol Chem       Date:  2003-05-30       Impact factor: 5.157

Review 8.  Tor signalling in bugs, brain and brawn.

Authors:  Estela Jacinto; Michael N Hall
Journal:  Nat Rev Mol Cell Biol       Date:  2003-02       Impact factor: 94.444

9.  TSC2 regulates VEGF through mTOR-dependent and -independent pathways.

Authors:  James B Brugarolas; Francisca Vazquez; Archana Reddy; William R Sellers; William G Kaelin
Journal:  Cancer Cell       Date:  2003-08       Impact factor: 31.743

10.  Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

Authors:  A H Brand; N Perrimon
Journal:  Development       Date:  1993-06       Impact factor: 6.868

View more
  145 in total

1.  Escherichia coli succinic thiolinase. Stoichiometry of phosphorylation and coenzyme A binding.

Authors:  C M Bowman; J S Nishimura
Journal:  J Biol Chem       Date:  1975-07-25       Impact factor: 5.157

2.  mTOR activity under hypoxia.

Authors:  Douangsone D Vadysirisack; Leif W Ellisen
Journal:  Methods Mol Biol       Date:  2012

Review 3.  Stress responses affecting homeostasis of the alveolar capillary unit.

Authors:  Rubin M Tuder; Toshinori Yoshida
Journal:  Proc Am Thorac Soc       Date:  2011-11

Review 4.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

Review 5.  Control of translation initiation through integration of signals generated by hormones, nutrients, and exercise.

Authors:  Scot R Kimball; Leonard S Jefferson
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

6.  Smoking and emphysema: the stress connection.

Authors:  Leif W Ellisen
Journal:  Nat Med       Date:  2010-07       Impact factor: 53.440

Review 7.  The regulation of organ size in Drosophila: physiology, plasticity, patterning and physical force.

Authors:  Alexander W Shingleton
Journal:  Organogenesis       Date:  2010 Apr-Jun       Impact factor: 2.500

8.  The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1.

Authors:  Liron Bar-Peled; Lynne Chantranupong; Zhi-Yang Tsun; Roberto Zoncu; Tim Wang; Choah Kim; Eric Spooner; David M Sabatini
Journal:  Mol Cell       Date:  2013-10-03       Impact factor: 17.970

9.  Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/REDD1 signaling axis in head and neck squamous cell carcinoma.

Authors:  Abraham Schneider; Rania H Younis; J Silvio Gutkind
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

10.  Elevated corticosterone associated with food deprivation upregulates expression in rat skeletal muscle of the mTORC1 repressor, REDD1.

Authors:  Nora K McGhee; Leonard S Jefferson; Scot R Kimball
Journal:  J Nutr       Date:  2009-03-18       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.